YTENQ (Yield10 Bioscience) Change In Receivables: $0.00 Mil (TTM As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YTENQ Yield10 Bioscience Inc YTENQ
16 GF Score
Price $0.00
View Full Analysis

What is Yield10 Bioscience Change In Receivables?

Yield10 Bioscience YTENQ 16 Change In Receivables is $0.00 Mil as of Jun. 2024. GuruFocus rates YTENQ with a GF Score™ of 16/100.

Yield10 Bioscience's change in receivables for the quarter that ended in Jun. 2024 was $0.00 Mil. It means Yield10 Bioscience's Accounts Receivable stayed the same from Mar. 2024 to Jun. 2024 .

Yield10 Bioscience's change in receivables for the fiscal year that ended in Dec. 2023 was $0.03 Mil. It means Yield10 Bioscience's Accounts Receivable declined by $0.03 Mil from Dec. 2022 to Dec. 2023 .

Yield10 Bioscience's Accounts Receivable for the quarter that ended in Jun. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Yield10 Bioscience's Days Sales Outstanding for the three months ended in Jun. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Yield10 Bioscience's liquidation value for the three months ended in Jun. 2024 was $-8.47 Mil.

Yield10 Bioscience  (OTCPK:YTENQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Yield10 Bioscience's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.45*91
=0.00

2. In Ben Graham's calculation of liquidation value, Yield10 Bioscience's accounts receivable are only considered to be worth 75% of book value:

Yield10 Bioscience's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.733-9.206+0.75 * 0+0.5 * 0
=-8.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yield10 Bioscience Change In Receivables Related Terms

Yield10 Bioscience Change In Receivables Historical Data

* Premium members only.

The historical data trend for Yield10 Bioscience's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yield10 Bioscience Change In Receivables Chart

Yield10 Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 -0.02 -0.09 0.17 0.03

Yield10 Bioscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
YTENQ
16GF Score
Yield10 Bioscience Inc YTENQ
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yield10 Bioscience Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.00 Mil mean?
Yield10 Bioscience (YTENQ) has a Change In Receivables of $0.00 Mil as of Jun. 2024. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Yield10 Bioscience and its competitors.
Is Yield10 Bioscience's Change In Receivables too high?
Yield10 Bioscience's current Change In Receivables is $0.00 Mil. Overall, Yield10 Bioscience has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Yield10 Bioscience's Change In Receivables compare to GNVR and CTVA?
Yield10 Bioscience's Change In Receivables of $0.00 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Agriculture company?
A good Change In Receivables depends on the Agriculture industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Yield10 Bioscience and its competitors. Yield10 Bioscience's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yield10 Bioscience stock overvalued right now?
Yield10 Bioscience (YTENQ) has a current Change In Receivables of $0.00 Mil. The current Change In Receivables is $0.00 Mil. Yield10 Bioscience's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Yield10 Bioscience (YTENQ), the current Change In Receivables is $0.00 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yield10 Bioscience Business Description

Address 19 Presidential Way, Woburn, MA, USA, 01801
Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed Camelina sativa as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics.
16GF Score

Get the complete analysis for YTENQ

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price